Mechanistic studies reveal that Fe-CDs can selectively promote tumor cell apoptosis through regulating PARP/Caspase 3/Caspase 9/BAX proteins, and activate antitumoral macrophages by inhibiting the IL-10/Arg-1 axis, which contributed to the superior anti-tumor performance of Fe-CDs. Here, CASP9 is linked to neoplasm.